title: Nonvalidated therapies and HIV disease. McGill/Boston Research Group.
abstract: As more AIDS patients seek access to nonvalidated therapies, Authorized Investigational Units can preserve the integrity of clinical trials, protect patients' interests, and enhance clinicians' flexibility.
authors.affiliation: McGill Centre for Medicine, Montreal, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Freedman
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000529:Complementary Therapies; D035061:Control Groups; D033161:Government Regulation; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D010344:Patient Advocacy / Q000331:legislation & jurisprudence*; D018579:Patient Selection; D026684:Personal Autonomy; D035842:Research Subjects; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation